Vanberra Signal
Free trial

Adorial

Curated by Signal

Drug Discovery company using a proprietary in silico genomics platform

Health Technologyadorial.com

Overview

Adorial is a virtual drug discovery company using a proprietary in silico genomics platform to identify novel drug targets. Adorial was spun-out from PGXIS in 2015. Offers a technology platform, Taxonomy3 for the analysis of genetic dataset and will allow broad screening for gene-gene interactions. Adorial identified 18 novel drug targets causally related to Rheumatoid Arthritis {RA) using Taxonomy3. These have not been identified in any previous published genetic analysis of RA,

Key facts

Founded
2014
Headquarters
High Wycombe, United Kingdom
Stage
Sign up to view
Industry
Health Technology

Contact

Primary office
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • CARiFiT

    Provider of an online live fitness training plan for the post-natal condition

    Health TechnologyHeadley, United Kingdom

  • Cosmetic Surgery

    Online listing platform to find cosmetic surgeons

    Health TechnologyBirmingham, United Kingdom

  • Giloys

    Mobile application for health records management

    Health TechnologyLondon, United Kingdom

About Adorial

What does Adorial do?

Adorial is a virtual drug discovery company using a proprietary in silico genomics platform to identify novel drug targets.

Where is Adorial headquartered?

Adorial is headquartered in High Wycombe, United Kingdom.

When was Adorial founded?

Adorial was founded in 2014.

Which sector is Adorial in?

Adorial operates in Health Technology.

Who are Adorial's competitors?

Companies similar to Adorial include CARiFiT, Cosmetic Surgery, and Giloys.